Evaluating an ex vivo organ culture system for predicting response to neoadjuvant chemotherapy in breast cancer patients

被引：0
|
作者：
Gal-Yam, Einav Nili
Sklair-Levi, Miri
Vachnish, Yaeli
Balint-Lahat, Nora
Morzaev-Sulzbach, Dana
Bakalenik-Gavry, Michal
Fearmann, Renata
Halshtok, Osnat
Shalmon, Anat
Gotlieb, Michael
Yagil, Yael
Levanon, Keren
Bernstein-Molho, Rinat
Itay, Amit
Shapira-Rotenberg, Tali
Globus, Opher
Barshack, Iris
Salpeter, Seth
Bar, Vered
Aharon, Sara
Turovsky, Lubov
Zundelevich, Adi
Mallel, Giuseppe
Shahar, Hamutal
Shapira, Hagit
Dadiani, Maya
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P1-08-25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-08-25
引用
收藏
页数：3
相关论文
共 50 条
  • [31] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Solodyannikova, O.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S30 - S30
  • [32] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [33] Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients
    Solodyannikova, O.
    Voit, N.
    Dzhuzha, D.
    Sukach, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S305 - S305
  • [34] Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer
    Kang, S. Y.
    Jung, Y. S.
    Kim, K. S.
    BREAST, 2011, 20 : S48 - S48
  • [35] The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients
    Ruiz, C
    Barros, A
    Motta, E
    Pinotti, J
    BREAST, 1997, 6 (05): : P949 - P949
  • [36] Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
    Marjolijn M. Ladan
    Titia G. Meijer
    Nicole S. Verkaik
    Cecile de Monye
    Linetta B. Koppert
    Esther Oomen-de Hoop
    Carolien H. M. van Deurzen
    Roland Kanaar
    Julie Nonnekens
    Dik C. van Gent
    Agnes Jager
    npj Breast Cancer, 9
  • [37] Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
    Ladan, Marjolijn M.
    Meijer, Titia G.
    Verkaik, Nicole S.
    de Monye, Cecile
    Koppert, Linetta B.
    Oomen-de Hoop, Esther
    van Deurzen, Carolien H. M.
    Kanaar, Roland
    Nonnekens, Julie
    van Gent, Dik C.
    Jager, Agnes
    NPJ BREAST CANCER, 2023, 9 (01)
  • [38] Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
    Motterle, Giovanni
    Andrews, Jack R.
    Morlacco, Alessandro
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY FOCUS, 2020, 6 (04): : 642 - 649
  • [39] Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
    Zhou, Jiali
    Lu, Jinghui
    Gao, Chen
    Zeng, Jingjing
    Zhou, Changyu
    Lai, Xiaobo
    Cai, Wenli
    Xu, Maosheng
    BMC CANCER, 2020, 20 (01)
  • [40] Factors predicting a pathological complete response following neoadjuvant chemotherapy for breast cancer
    Choi, H.
    Van Belle, V.
    Wildiers, H.
    Paridaens, R.
    Amant, F.
    Van Limbergen, E.
    Moerman, P.
    Smeets, A.
    Vergote, I.
    Neven, P.
    EJC SUPPLEMENTS, 2010, 8 (03): : 66 - 67
12345